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Background: The angiographic patency of composite Y internal thoracic artery–
saphenous vein grafts has not been investigated in detail.
Methods: Twenty-five patients who received composite Y internal thoracic artery–
saphenous vein grafts had control angiography and vasoactive challenges with
serotonin, acetylcholine, and isosorbide dinitrate at a mean of 2.5  1.2 years after
surgery.
Results: The perfect patency rate of composite Y internal thoracic artery–saphenous
vein grafts was 72% (18/25). The distal portion of the internal thoracic artery was
stringed in 4 patients and occluded in 2. The saphenous branch of the composite Y
internal thoracic artery–saphenous vein grafts was found patent in all patients except
1. No failures were reported in the proximal tract of the internal thoracic artery. The
distal tract of the internal thoracic artery showed reduced capacity of endothelium-
mediated relaxation.
Conclusion: The short-term patency of composite Y internal thoracic artery–saphe-
nous vein grafts is suboptimal and markedly influenced by distal runoff and native
flow competition.
Composite Y internal thoracic artery–saphenous vein grafts (YITA-SVs) represent an unusual type of coronary artery bypass conduit.As YITA-SV combines the best and the worst conduit used incoronary surgery, obvious theoretical perplexities exist regardingits use in uncomplicated cases. The only suggested scenario for theadoption of this type of graft configuration is the necessity to
minimize ascending aorta manipulation in patients with multivessel coronary dis-
ease and diffusely atherosclerotic ascending aorta.1-4 The very selected and rela-
tively uncommon indication and the fact that YITA-SVs have often been used as last
resort in extreme cases explain the absence of systematic angiographic studies of
these conduits and the lack of information on their patency in the years after surgery.
During the past 48 months we adopted this type of graft configuration in 28
patients. As YITA-SV can represent an interesting model of internal thoracic artery
flow diversion and “hybrid” vascular architecture, and due to the limited informa-
tion available on this issue, we decided to ask all our patients to undergo control
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angiography and to try to elucidate the vasoreactive char-
acteristics of YITA-SV by means of endovascular vasoac-
tive challenges.
Patients and Methods
Patient Population
From January 1999 to December 2002 YITA-SVs were used in 28
consecutive patients. These patients represent 0.7% of all coronary
artery bypass (CABG) procedures performed during that period.
The decision to adopt this unusual type of conduit was based on
the necessity to avoid aortic manipulation (due to severe ascending
aorta atherosclerosis, too short ascending aorta, or presence of an
ascending aorta prosthesis) coupled with the impossibility of using
the additional arterial conduits in use at our institution: the right
internal thoracic and the radial artery. All patients survived surgery
and were discharged from the hospital in good condition. Twenty-
five of these patients agreed to undergo control angiography and
represent the objects of this study. The main preoperative features
of the patients and the contraindications to use additional arterial
conduits are reported in Tables 1 and 2. Patients were in their
eighth decade, had poor left ventricular function and limited func-
tional capacity, and had a high incidence of associated pathologies.
Surgical Technique
The operation performed was isolated CABG in 19 patients,
CABG and aortic valve replacement in 4, and CABG plus aortic
valve and ascending aorta replacement in the remaining 2. All
isolated CABG procedures were performed on the beating heart.
The YITA-SV was performed using the standard technique. After
completion of the proximal anastomosis the internal thoracic artery
(ITA) was always anastomosed to the left anterior descending
artery (LAD) and the saphenous vein (SV) to either a diagonal
branch (1 patient), an obtuse marginal artery (11 patients), a
posterolateral branch (8 patients), or the posterior descending
artery (5 patients).
In all patients 2 coronary anastomoses were performed; myo-
cardial revascularization was complete in 13 patients (52%) and
incomplete in the remaining 12. In consideration of the poor
systemic and cardiac status of these patients and of the consider-
able operative risk (see Table 1), this high degree of incomplete
revascularization was judged acceptable.
Angiographic Protocol
Patients were studied in a fasting state, after premedication with
oral diazepam (10 mg). Selective YITA-SV angiography was
performed by percutaneous left radial (n  24) or right femoral
approach (n  1). Thoracic artery catheters (5F or 6F; Boston
Scientific, Natick, Mass) were used as appropriate to obtain opti-
mal YITA-SV visualization and selective contrast medium injec-
tion. Multiple angiographic views were obtained to detect signif-
icant stenosis at any YITA-SV level; Thrombosis in Myocardial
Infarction flow grade was visually estimated separately by 2 dif-
ferent observers.
Pharmacological stimulation was then started according to a
previously described protocol,5 using serotonin, isosorbide dini-
trate, acetylcholine, and isosorbide dinitrate, as follows.
Serotonin hydrochloride 105 mol/L (ICN Pharmaceuticals
Inc, Costa Mesa, Calif) was selectively injected into the YITA-SV
graft at a rate of 3 mL/min for 3 minutes; at the end of the
serotonin challenge 2 mg of isosorbide dinitrate was injected into
the conduit. After a 20-minute period acetylcholine chloride 106
mol/L (Miovisin, Farmigea, Italy) was selectively injected into the
YITA-SV at a rate of 1.5 mL/min for 3 minutes; again at the end
of the acetylcholine infusion 2 mg of isosorbide dinitrate was
injected into the graft. Drug infusion was always performed under
electrocardiogram and invasive blood pressure monitoring. At the
end of each step of the protocol a cine run was performed, keeping
fixed angiographic view.
Digital angiograms were then analyzed using computerized
quantitative angiography (Medis, Neuen, The Netherlands). Due to
the complex vascular architecture of the graft and for a more
detailed angiographic analysis of the conduit, the YITA-SV was
divided in 3 vascular segments: proximal ITA (proximal to the
saphenous vein anastomosis), distal ITA (distal to the saphenous
vein anastomosis), and SV graft. The 3 segments were measured in
end-diastolic frames after proper catheter calibration as follows:
● proximal ITA: 10 to 15 mm proximal to the SV anastomosis;
TABLE 1. Preoperative characteristics of the patients
Male/female 19/6
Mean age 75.5 8.9
History
hypertension 15 (60%)
diabetes 19 (76%)
smoking 7 (28%)
dyslipemia 12 (48%)
family history of CAD 5 (20%)
Peripheral vasculopathy 21 (84%)
Chronic obstructive pulmonary disease 18 (72%)
Previous stroke 13 (52%)
Previous AMI 21 (84%)
Canadian Cardiovascular Society angina class
I 10 (40%)
II 7 (28%)
III 8 (32%)
Number of diseased vessels
2 8 (32%)
3 12 (48%)
LMCA 5 (20%)
Left ventricular ejection fraction 0.42 0.11
AMI, Acute myocardial infarction; CAD, coronary artery disease; LMCA,
left main coronary artery.
TABLE 2. Contraindications to the use of additional arterial
conduits
Contraindications to BITA use
Insulin-dependent diabetes 16
Severe chronic obstructive pulmonary disease 14
Previous mediastinal irradiation 1
Obesity 9
Contraindications to RA use
Lack of preoperative evaluation of forearm vasculature 19
Insufficient ulnar compensation 6
BITA, Bilateral internal thoracic arteries; RA, radial artery.
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● distal ITA: 10 to 15 mm distal to the SV anastomosis;
● SV graft: 10 to 20 mm distal to anastomosis with the ITA.
Perfect patency was defined as the absence of any irregularity at
the level of all 3 vascular segments examined and of all 3 anas-
tomoses.
Patients did not received vasoactive medications in the 24
hours before the procedure. Written informed consent was ob-
tained from each patient.
Statistical Analysis
Chi-square or Fisher exact tests were used to compare discrete
parameters. Analysis of Variance (ANOVA) for repeated measures
was used to test differences after vasoactive challenges; post hoc
comparison was performed by Neuman-Keuls test. Analysis was
conducted using the software Statistica for Windows 4.1 (Statsoft,
Inc, Tulsa, Okla).
Results
Angiographic Patency
Control angiography was performed at a mean of 2.5  1.2
years after surgery. Eighteen of the 25 grafts were perfectly
patent (72%); the distal portion of the ITA was stringed in
4 patients (Figure 1) and occluded in 2 (Figure 2). The
saphenous branch of the YITA-SV was found patent in all
patients except 1. No failures were reported in the proximal
tract of the ITA. Overall, the short-term YITA-SV graft
patency was 22/25 (88%).
All cases of ITA malfunction were reported in the part of
the ITA distal to the SV anastomosis and always in patients
in whom the artery was used to revascularize a coronary
artery with 70% stenosis (6/10 vs 0/15; P  .02).
Distal (but not proximal) ITA graft diameter was signif-
icantly influenced by target vessel stenosis (Figure 3). Mean
proximal ITA diameter was 2.71  0.21 mm for patients
with 70% LAD stenosis versus 2.67  0.18 mm in pa-
tients with 70% lesion (P  .47); in contrast, distal ITA
diameter was 1.78 0.18 mm for patients with70% LAD
stenosis versus 2.25  0.09 mm in patients with 70%
lesion (P  .001).
Clinical and Scintigraphic Status
At the time of the study no patient had angina recurrence;
stress myocardial scintigraphy demonstrated some degree
of inducible ischemia in 11 patients and absence of
ischemia in the remaining 14. All 7 patients with
YITA-SV malfunction (6 ITAs and 1 great SV) had
scintigraphic evidence of ischemia in the graft territory.
In the remaining patients ischemia was localized in non-
Figure 1. Stringed distal internal thoracic artery in a Y internal thoracic artery–saphenous vein graft. The internal
thoracic artery shows diffuse narrowing of its distal portion. Arrow indicates thoracic artery–saphenous vein
anastomosis. GSV, Great saphenous vein; LAD, left anterior descending artery; LITA prox, proximal left internal
thoracic artery; LITA dist, distal left internal thoracic artery.
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grafted territories and related to the incompleteness of
surgical revascularization. Due to poor functional capac-
ity, old age, and absence of symptoms, no patient was
submitted to further invasive procedure.
Vasoreactivity
YITA-SV reactions to endovascular vasoactive challenges
are summarized in Table 3. Proximal and distal ITAs did not
significantly react to serotonin infusion and showed signif-
icant dilatation after the administration of isosorbide dini-
trate. The proximal part of the ITA also showed significant
capacity of endothelium-dependent vasodilatation, whereas
the distal tract of the artery dilated only slightly following
acetylcholine challenge. The SV branch reacted to both
serotonin and isosorbide dinitrate but did not show signifi-
cant endothelium-mediated relaxation.
Discussion
Anastomosing the proximal portion of an SV to an ITA
creates a “hybrid” arteriovenous graft that shares the bio-
logic and functional characteristics of the best and the worst
conduit used for CABG procedures. In the past it has been
suggested that YITA-SV can represent the appropriate so-
lution in cases of severe ascending aorta atherosclerosis,
particularly when there is some contraindication to the use
on non–left ITA arterial grafts.1-4
Our series reports the angiographic results and vasore-
active profile of 25 YITA-SVs at a mean interval of 2.5
years from surgery. We found that the overall patency
(22/25  88%) was lower than that reported for single ITA
and for composite all-arterial conduits.6,7 The great majority
of graft malfunctions (string or occlusion) were localized in
the portion of the ITA distal to the SV anastomosis and were
reported when the artery was used to revascularize target
vessels with a moderate (70%) stenosis.
Theoretically YITA-SV represent an interesting model
of ITA flow diversion. The SV graft can be regarded as a
major ITA collateral branch whose caliber is significantly
larger than that of the main artery itself. This situation
creates the possibility of a significant flow diversion from
the ITA to the SV; flow steal is even enhanced when the
ITA is anastomosed to a coronary vessel with moderate
stenosis. ITA side branch flow steal has been denied in
single ITA grafts8,9; however, the diameter and length of the
SV grafts proximally anastomosed to the artery are larger
than those of the ITA side branches, and the YITA-SV
represents a hemodynamic model that cannot be compared
with the single ITA with its natural side branches.
Although in more physiologic situations the ITA is able
to adapt to a wide flow range without occlusion, the hemo-
dynamic condition created by the anastomosis of a large
conduit to the proximal part of the artery renders YITA-SV
more susceptible to the detrimental effect of chronic native
competitive flow. It is interesting to note that this depen-
dence of Y graft patency from flow competition has not
been reported in angiographic series where the graft was
constructed by anastomosing 2 arterial conduits (usually 2
ITAs or the ITA and a radial artery).6,7 It must be consid-
ered that the SV is larger and less reactive than all arterial
conduits and is likely to offer less resistance to flow. It is
then conceivable that flow diversion from the main stem of
the Y graft is higher when the side branch is represented by
an SV instead of a right ITA or a radial artery, rendering
YITA-SV more vulnerable to native competitive flow.
The portion of the ITA distal to the SV also exhibited a
lower capacity of endothelium-dependent vasodilatation
(see Table 3); as it is well known that flow and shear stress
are major determinant of nitric oxide (NO) production and
endothelium-mediated dilatation,10 it seems highly likely
Figure 2. Occluded distal internal thoracic artery in a Y internal
thoracic artery–saphenous vein graft. The distal tract of the internal
thoracic artery results occluded; of note, injection in the left coro-
nary system consents visualization of the distal part of the internal
thoracic artery indicating a patent distal anastomosis. Large arrow
indicates the presumed level of thoracic artery–saphenous vein
anastomosis, whereas small arrows indicate clips on the occluded
portion of the internal thoracic artery. GSV, Great saphenous vein;
LITA prox, proximal left internal thoracic artery.
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that reduced NO synthesis due to low flow in the distal ITA
could have played a causal role in graft malfunction and
occlusion.
YITA-SV have been proposed for complex technical
settings and in high-risk patients and, in this view, the
suboptimal patency rate that we have found could be con-
sidered acceptable. However, our findings show that this
type of graft configuration jeopardizes the distal tract of the
ITA, placing at risk the most important myocardial territory.
When adopting this type of conduit surgeons must be aware
of this possibility and consider eventual alternative techni-
cal solutions.
In our institution after evaluation of the present data we
have abandoned the use of these composite grafts. In the
situations where we used YITA-SV we now adopt 2 differ-
ent solutions:
● performance of an all-arterial Y graft using alternative
arterial conduits such as the inferior epigastric or gastro-
epiploic arteries or even the radial or right ITAs if the risk
associated with their use is judged less important than the
possibility of performing 1 additional graft;
● incomplete revascularization by a single ITA graft on
the LAD with eventual successive percutaneous treat-
ment of the non-LAD vessels.11
Figure 3. Caliber reduction between proximal and distal tract of the internal thoracic artery in an Y internal
thoracic artery–saphenous vein graft. Marked reduction of internal thoracic artery diameter is evident between the
portion of the artery proximal and distal to the saphenous vein anastomosis. Arrow indicates thoracic artery–
saphenous vein anastomosis. GSV, Great saphenous vein; LAD, left anterior descending artery; LITA prox, proximal
left internal thoracic artery; LITA dist, distal left internal thoracic artery.
TABLE 3. Mean diameters after endovascular vasoactive challenges
Baseline Acetylcholine Serotonin Isosorbide dinitrate
Proximal ITA (mm) 2.88 0.10 2.96 0.11* 2.86 0.09 2.98 0.11*
Distal ITA (mm) 2.11 0.05† 2.13 0.03 2.09 0.03 2.23 0.06*
Saphenous vein (mm) 3.78 0.31‡ 3.74 0.33 3.51 0.25* 4.01 0.20*
ITA, Internal thoracic artery.
*P  .05 vs baseline.
†P  .001 vs proximal ITA diameter.
‡P  .001 vs proximal and distal ITA diameter.
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